Specificity of antisera produced against bleomycin
- PMID: 72602
Item in Clipboard
Specificity of antisera produced against bleomycin
Cancer Treat Rep.
1977 Nov.
Abstract
The specificity of antisera produced in a goat or rabbit for use in bleomycin radioimmunoassay has been examined using competitive experiments employing several bleomycin analogs. These studies demonstrate that the antiserum distinguished alterations in both the nucleus and the terminal structure of the molecule. Removal of the terminal structure or addition of an aminosugar moiety in the bleomycin nucleus resulted in a significant decrease in immunoreactivity. Antisera produced in goat and rabbit hosts had different specificity for the terminal structure. The goat antisera demonstrated greater specificity for the terminal side chain than the rabbit antisera although this may not reflect a species-related event.
Similar articles
-
Radioimmunoassay of bleomycin.Cancer Res. 1976 Apr;36(4):1418-21. Cancer Res. 1976. PMID: 56999
-
A radioimmunoassay for tallysomycin.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1829-32. Cancer Treat Rep. 1979. PMID: 93510
-
Radioimmunoassay of bleomycin in plasma and urine.Br J Cancer. 1977 Jun;35(6):822-7. doi: 10.1038/bjc.1977.124. Br J Cancer. 1977. PMID: 68783 Free PMC article.
-
Specificity of antisera produced against mitomycin C.Cancer Treat Rep. 1983 Dec;67(12):1079-84. Cancer Treat Rep. 1983. PMID: 6418380
-
Enzyme immunoassay for pepleomycin, a new bleomycin analog.Cancer Res. 1981 Oct;41(10):4121-6. Cancer Res. 1981. PMID: 6169433
Cited by
-
Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118. Cancer Chemother Pharmacol. 1978. PMID: 86392 No abstract available.
-
The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011. Cancer Chemother Pharmacol. 1980. PMID: 6994913 Review. No abstract available.
-
Bleomycin clinical pharmacology by radioimmunoassay.Cancer Chemother Pharmacol. 1982;9(1):22-5. doi: 10.1007/BF00296756. Cancer Chemother Pharmacol. 1982. PMID: 6183016
-
Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.Cancer Chemother Pharmacol. 1979;3(1):33-40. doi: 10.1007/BF00254417. Cancer Chemother Pharmacol. 1979. PMID: 93987 No abstract available.